Curative Raises $150M to Expand No-Cost Preventive Care Insurance Plans

Curative, a healthcare startup transitioning from COVID-19 testing to health insurance, secured over $150 million in Series B funding, elevating its valuation to $1.275 billion. The company offers insurance plans with no out-of-pocket costs for members who complete an annual preventive health visit, currently operating in Texas, Florida, and Georgia. The recent funding will enable Curative to expand nationally, initially targeting the Mid-Atlantic region, while enhancing member engagement, AI capabilities, and provider network development. Serving over 165,000 members across more than 1,200 employer clients, Curative aims to address challenges within the healthcare industry by aligning incentives toward preventative care and healthier outcomes. Investor interest highlights the potential for employer-based insurance models that foster improved health metrics. This expansion reflects ongoing shifts in the insurance market toward innovative plan designs leveraging technology and preventive care incentives.